Literature DB >> 9409593

Descending thoracic aorta-to-femoral artery bypass grafts.

P Sapienza1, A Mingoli, R J Feldhaus, F Napoli, A Marsan, M Franceschini, L di Marzo, A Cavallaro.   

Abstract

BACKGROUND: Descending thoracic aorta-to-femoral artery (DTAFA) bypass graft is an alternative procedure to revascularize lower limbs.
METHODS: Between 1976 and 1996, 41 patients underwent DTAFA bypass grafts. Operative indications consisted of previous abdominal graft thrombosis (22 cases, group 1), abdominal operations (8, group 2), initial vascular operation in the presence of difficult aortas (6, group 3), and infection of aortic grafts (5, group 4).
RESULTS: Perioperative mortality was 5%. Cumulative 10-year primary patency, limb salvage, and survival rates were 64%, 79%, and 55%, respectively. Breaking down the result on the basis of the four groups, DTAFA bypass grafts performed for infection of previous aortic grafts had a significantly lower primary patency rate (25% at 24 months; P < 0.004) with dismal limb salvage (31% at 24 months; P < 0.001) and survival rates (0% at 24 months; P < 0.005).
CONCLUSIONS: DTAFA bypass grafts can be safely and durably used in patients who had thrombosis of previous abdominal grafts or had a difficult abdomen or as the initial vascular operation in the presence of difficult aortas. Conversely, dismal results are obtained in the treatment of aortic graft infection.

Entities:  

Mesh:

Year:  1997        PMID: 9409593     DOI: 10.1016/s0002-9610(97)00184-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Primary bypass surgery from the descending aorta to the iliac arteries for a severely calcified aorta: report of two cases.

Authors:  Osamu Sato; Hiroyuki Okamoto; Harunobu Matsumoto; Kouji Ogata; Keisuke Kondoh
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Contemporary outcomes of thoracofemoral bypass.

Authors:  Jeffrey D Crawford; Salvatore T Scali; Kristina A Giles; Martin R Back; Javairiah Fatima; Dean K Arnaoutakis; Scott A Berceli; Gilbert J Upchurch; Thomas S Huber
Journal:  J Vasc Surg       Date:  2018-10-03       Impact factor: 4.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.